In PC tissue, high-level LC3B expression is associated with key clinicopathological indicators of aggressive disease, including high Gleason scores and advanced tumor grades, highlighting its involvement in tumor progression and aggressive growth [19]. The gene discussed is MAP1LC3B; the disease is pachyonychia congenita.